• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

Industry Audit + Company of the Year 2008

Article

Pharmaceutical Executive

Pharmaceutical ExecutivePharmaceutical Executive-09-01-2008
Volume 0
Issue 0

Pharm Exec's 7th annual review of the top companies. We slice and dice the numbers to see who's the best a what. (pdf)

External Link - article-550197.pdf

Articles in this issue
Industry Audit + Company of the Year 2008
The New Code
i4-548226-1408670152557.gif
Publish or Perish
i4-548215-1408670183813.gif
How Do You Solve a Problem Like Manufacturing?
i2-548221-1408670165725.gif
Foreign Affairs
Tapping the Fount
i3-548220-1408670169496.gif
The M&A Numbers
i3-548219-1408670172284.gif
The Salesforce Software Shift
i1-548217-1408670178681.jpg
Attack of the Junk
i1_t-548224-1408670158362.gif
Unleash the Dragon 2
i2-548225-1408670156163.gif
Place Your Bets
The Orphan Opportunity
i1-548218-1408670175812.jpg
Considering Consumer Change: Q&A with Jim Joseph, Saatchi & Saatchi
Doing More With Less
Recent Videos
Related Content
Kirsten Jacobs

The Lifespan of Mature Drugs in 2025: Q&A with Kirsten Jacobs

Mike Hollan
December 18th 2024
Article

PharmaLex’s chief strategy officer discusses strategies to improve monetization for these drugs.

Seeking More Value, Less Cost

Seeking More Value, Less Cost

Michael Christel
December 17th 2024
Article

The biosimilars market in the US is on the rise, but barriers to greater adoption remain.

Dealmaking Dormant No More

Dealmaking Dormant No More

Mike Hollan
December 17th 2024
Article

Unleashed demand over the past year characterizes the M&A picture in pharma.

The Recipe for Relief: Overcoming Industry Pain Points

The Recipe for Relief: Overcoming Industry Pain Points

Diane Petrone
December 13th 2024
Article

Why investing in people and training can help drugmakers deal with six pressing challenges in particular in the year ahead.

Pharma Forecasting: Key Markets Investors Can’t Ignore

Pharma Forecasting: Key Markets Investors Can’t Ignore

Na Wei;Joerg Tritschler;Martin Slusarczyk, PhD
December 13th 2024
Article

The importance of expanding your pharma sales forecasting horizon beyond the US. Learn how to effectively navigate country-specific regulatory red flags.

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Introducing Agentic AI: Its Revolutionary Potential in Pharma

Tanveer Ahmed Nasir;Pooja Jain
December 13th 2024
Article

A look at the promise and opportunities from this new and advanced type of AI in transforming commercial planning and execution for life sciences companies.